Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/03/2003 | EP1340510A1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
09/03/2003 | EP1340509A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
09/03/2003 | EP1340508A1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
09/03/2003 | EP1340505A2 Therapeutic use of cis-element decoys in vivo |
09/03/2003 | EP1340500A1 Antidiabetic agents |
09/03/2003 | EP1339867A2 ALTERATIONS IN THE LONG QT SYNDROME GENES i KVLQT1 /i AND i SCN5A /i AND METHODS FOR DETECTING SAME |
09/03/2003 | EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
09/03/2003 | EP1339854A2 Lipid metabolism enzymes |
09/03/2003 | EP1339840A2 Schizophrenia-related voltage-gated ion channel gene and protein |
09/03/2003 | EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
09/03/2003 | EP1339834A2 Enzymes |
09/03/2003 | EP1339748A2 G-protein coupled receptors |
09/03/2003 | EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
09/03/2003 | EP1339721A2 Hydroxyesters of 7-desmethylrapamycin |
09/03/2003 | EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
09/03/2003 | EP1339717A1 Novel carbamate-substituted pyrazolopyridine derivatives |
09/03/2003 | EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives |
09/03/2003 | EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
09/03/2003 | EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists |
09/03/2003 | EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists |
09/03/2003 | EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
09/03/2003 | EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
09/03/2003 | EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
09/03/2003 | EP1339698A2 Pyrimidine derivatives |
09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
09/03/2003 | EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
09/03/2003 | EP1339691A1 Novel compounds |
09/03/2003 | EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
09/03/2003 | EP1339684A1 Mch antagonists and their use in the treatment of obesity |
09/03/2003 | EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists |
09/03/2003 | EP1339675A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
09/03/2003 | EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
09/03/2003 | EP1339662A1 Novel estrogen receptor ligands and methods iii |
09/03/2003 | EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
09/03/2003 | EP1339440A1 An implantable or insertable therapeutic agent delivery device |
09/03/2003 | EP1339429A2 Composition containing statins and calcium for improved cardiovascular health |
09/03/2003 | EP1339428A1 Inhalation of nitric oxide |
09/03/2003 | EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
09/03/2003 | EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines |
09/03/2003 | EP1339409A1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
09/03/2003 | EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
09/03/2003 | EP1339403A2 Repinotan kit |
09/03/2003 | EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
09/03/2003 | EP1339385A1 Skin cream stimulating the surface bloodstream |
09/03/2003 | EP1194403B1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
09/03/2003 | EP1183046B1 Aminotetralin derivative for the therapy of cardiovascular diseases |
09/03/2003 | EP1140187B1 Combinations of an ibat inhibitor and a mtp inhibitor for cardiovascular indications |
09/03/2003 | EP1090014B1 Arylsulfonanilide phosphates |
09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
09/03/2003 | EP0977741B1 Substituted phenyl derivatives, their preparation and use |
09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
09/03/2003 | EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
09/03/2003 | EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
09/03/2003 | EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy |
09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
09/03/2003 | CN1440412A Thienopyrrolidinones |
09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
09/03/2003 | CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
09/03/2003 | CN1440407A Bispidine compounds and their use in treatment of cardiac arrhythmias |
09/03/2003 | CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders |
09/03/2003 | CN1440401A Amino substituted dibenzothiophene derivatives for treatmnt of disorders mediated by NP Y5 receptor |
09/03/2003 | CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides |
09/03/2003 | CN1440398A Substituted phthalides as anti-convulsive drugs |
09/03/2003 | CN1440396A Colchinol derivatives as angiogenesis inhibitors |
09/03/2003 | CN1440395A COLCHINOL derivatives as vascular damaging agents |
09/03/2003 | CN1440392A Phenylpyridazine derivatives and drugs containing the same |
09/03/2003 | CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
09/03/2003 | CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt |
09/03/2003 | CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
09/03/2003 | CN1440290A 7-Hydroxyepiandrosterone having neuroprotective activity |
09/03/2003 | CN1440287A Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies |
09/03/2003 | CN1440283A Combination of organic compounds |
09/03/2003 | CN1440281A Medicine for reducing intraocular pressure |
09/03/2003 | CN1440256A Method and apparatus for stimulating sphenopalatine ganglion to modify properties of BBB and cerebral blood flow |
09/03/2003 | CN1439632A Sulfolipid compound with neural nourishing function and synthetic method and application thereof |
09/03/2003 | CN1439629A Laevo potassium aspartate material and preparation therefrom and preparing method thereof |
09/03/2003 | CN1439405A External used medicine against piles |
09/03/2003 | CN1439401A Chinese medicinal herb preparation for cardivascular diseases |
09/03/2003 | CN1439386A Hawthorn fruit cardiac stimulant |
09/03/2003 | CN1439372A Nisoldipine double layer penetrated pump control releasing tablets |
09/03/2003 | CN1439279A Luohan and cassia seed tea and its preparing method |
09/03/2003 | CN1120167C Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles having an affinity for alpha and/or 5HTIA receptors |
09/03/2003 | CN1120002C Application of ammonium nilrate in pharmaceutical industry, food and health-care product |
09/02/2003 | US6613942 Glucagon antagonists/inverse agonists |
09/02/2003 | US6613932 Prostaglandin derivatives |
09/02/2003 | US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
09/02/2003 | US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters |
09/02/2003 | US6613905 Chemokine receptor antagonists and methods of use therefor |
09/02/2003 | US6613874 Melanocortin receptor ligands |
09/02/2003 | US6613803 Treating, preventing or ameliorating pain |
09/02/2003 | US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
09/02/2003 | US6613801 Method for the synthesis of compounds of formula I and their uses thereof |
09/02/2003 | US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors |
09/02/2003 | US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
09/02/2003 | US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands |
09/02/2003 | US6613761 (3R,5S)-N- methanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl) -1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4, 1-benzoxazepine-3-acetamide, used as antilipemic agents and enzyme inhibitors |